Behavioral and psychiatric adverse events associated with antiepileptic drugs commonly used in pediatric patients.
about
Off-label psychopharmacologic prescribing for children: history supports close clinical monitoringComprehensive overview: efficacy, tolerability, and cost-effectiveness of clobazam in Lennox-Gastaut syndromeImpact of early life exposure to antiepileptic drugs on neurobehavioral outcomes based on laboratory animal and clinical research.Valproic acid-induced abnormal behaviorCommentary: Pediatric epilepsy: a good fit for pediatric psychologists.Uninformed clinical decisions resulting from lack of adherence assessment in children with new-onset epilepsyTreatment of epilepsy in children with developmental disabilities.GABAergic drugs in the treatment of epilepsy: modern or outmoded?Management of psychiatric and neurological comorbidities in epilepsy.The importance of assessing behaviour and cognition in antiepileptic drug trials in children and adolescents.Cognitive and behavioral outcomes among seizure-controlled children with partial epilepsy on antiepileptic drug monotherapy.Prediction of specific depressive symptom clusters in youth with epilepsy: The NDDI-E-Y versus Neuro-QOL SF.Depression and mental health help-seeking behaviors in a predominantly African American population of children and adolescents with epilepsy.Adjunctive perampanel in adolescents with inadequately controlled partial-onset seizures: A randomized study evaluating behavior, efficacy, and safety.Effect of early postnatal exposure to valproate on neurobehavioral development and regional BDNF expression in two strains of mice.Antiepileptic drugs: Impacts on human serum paraoxonase-1.
P2860
Q21202071-B1F96E7E-9140-4CCA-BE7D-96FC53660F21Q26823805-B84FDFB4-3290-4D02-BA4F-CDB04090D1B3Q30443028-D5CE803A-0172-49CF-A363-D0E4FB545628Q33671151-C97380A0-A49A-4309-92F3-62FA7FBEFECDQ34811356-35DB583C-40B2-4D01-ADDC-A56E1E0AD03FQ36443286-4AF44E2C-CD9B-43A2-9E27-E3F3CD2DAB2AQ37803574-5D977166-6941-4B4C-B9D6-17781F5C2BD1Q37856281-14121196-939E-4CF2-BE59-1B9A6014799FQ38702125-A8B55A94-1AF5-4829-8E7F-7FCA935A6DB1Q38779934-F6326D85-DEC2-4D1E-BDED-705988E3517EQ38806037-372B8387-01F4-4780-9419-6F59F4443330Q39361786-325FBE94-F22A-42FC-97E7-5521E56944C5Q46318966-0C0865D7-55C5-4C8D-BC7A-13C7A27CA586Q46408856-E9391411-F12B-4365-9151-D5BC12258EF4Q47327174-3A92DD82-0826-46BF-B498-CE5C5132A25AQ51229073-F9B797F8-94A0-4458-A138-978ABBB8BDB1
P2860
Behavioral and psychiatric adverse events associated with antiepileptic drugs commonly used in pediatric patients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Behavioral and psychiatric adv ...... ly used in pediatric patients.
@ast
Behavioral and psychiatric adv ...... ly used in pediatric patients.
@en
type
label
Behavioral and psychiatric adv ...... ly used in pediatric patients.
@ast
Behavioral and psychiatric adv ...... ly used in pediatric patients.
@en
prefLabel
Behavioral and psychiatric adv ...... ly used in pediatric patients.
@ast
Behavioral and psychiatric adv ...... ly used in pediatric patients.
@en
P2860
P1476
Behavioral and psychiatric adv ...... ly used in pediatric patients.
@en
P2093
Tracy A Glauser
P2860
P304
P356
10.1177/088307380401900104
P478
19 Suppl 1
P577
2004-08-01T00:00:00Z